What is NDC 82449-242?

82449-242 is the product NDC for Sugammadex Sodium, Sugammadex sodium 500 mg/5mL solution, listed with the FDA by STERISCIENCE SPECIALTIES PRIVATE LIMITED. It has 1 package NDC, shown above in 10- and 11-digit form.

STERISCIENCE SPECIALTIES PRIVATE LIMITED, NDC labeler code 82449. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sugammadex Sodium?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sugammadex Sodium NDC 82449-242 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)82449-242Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82449-0242Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82449-242-02	8244902420282449024202	10 SYRINGE in 1 CARTON (82449-242-02) / 5 mL in 1 SYRINGEMarketed from Jul 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sugammadex Sodium
Generic name (nonproprietary): sugammadex sodium
Active ingredients: Sugammadex sodium — 500 mg/5mL
Dosage form: Solution
Route: Intravenous
Labeler: STERISCIENCE SPECIALTIES PRIVATE LIMITEDNDC labeler code 82449
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218814
Marketing start: Jul 28, 2026
Listing expires: Dec 31, 2027
Other FDA classes: gamma-Cyclodextrins (Chemical structure)
Identifiers: Product ID 82449-242_57d290a8-9981-69a9-e063-6294a90ad9e2SPL ID 57d290a8-9981-69a9-e063-6294a90ad9e2SPL set ID 0379799d-b678-4eb1-8f15-7dd183ee2a6eRxCUI 2748156, 2748158UNII ERJ6X2MXV7UPC 0382449241016

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N482449024202 followed by a unit qualifier and the quantity

Package 82449-0242-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2026.

Indications (excerpt from the label)

Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information. Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82449-242

What is NDC 82449-242?: 82449-242 is the product NDC for Sugammadex Sodium, Sugammadex sodium 500 mg/5mL solution, listed with the FDA by STERISCIENCE SPECIALTIES PRIVATE LIMITED. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sugammadex Sodium.
What is the active ingredient?: Sugammadex sodium.
Who is the labeler?: STERISCIENCE SPECIALTIES PRIVATE LIMITED, NDC labeler code 82449. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sugammadex Sodium?: 3 other product NDCs are listed under this name. See all Sugammadex Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sugammadex Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sugammadex Sodium	Sugammadex sodium 200 mg/2mL	SolutionIntravenous	Par Health USA, LLC	42023-830	42023-0830-10
Sugammadex Sodium	Sugammadex sodium 500 mg/5mL	SolutionIntravenous	Par Health USA, LLC	42023-935	42023-0935-10
Sugammadex Sodium	Sugammadex sodium 200 mg/2mL	SolutionIntravenous	STERISCIENCE SPECIALTIES PRIVATE LIMITED	82449-241	82449-0241-02

Other NDCs under ANDA 218814

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218814
Product	Strength	Form · route	Labeler	Product NDC
Sugammadex Sodium	Sugammadex sodium 200 mg/2mL	SolutionIntravenous	Par Health USA, LLC	42023-830
Sugammadex Sodium	Sugammadex sodium 500 mg/5mL	SolutionIntravenous	Par Health USA, LLC	42023-935
Sugammadex Sodium	Sugammadex sodium 200 mg/2mL	SolutionIntravenous	STERISCIENCE SPECIALTIES PRIVATE LIMITED	82449-241